
Apple Inc. filed its reply brief in its cross-appeal against Epic Games Inc. arguing that there is nothing wrong with its “anti-steering provisions,” guidelines that supposedly curtail certain freedoms of app developers and limit their communications with app buyers. Apple argues that the district court wrongly decided the California Unfair Competition Law (UCL) issue, remarking that it is the first time a court enjoined conduct it found unfair under the UCL but reasonable under federal antitrust laws.
The case, initially brought by Epic in August 2020, avers that Apple has illegally monopolized the iOS app distribution market, exacting a supracompetitive fee from its third-party developers for the privilege of offering their apps for sale in the Apple App Store.
Last Thursday’s brief follows an initial appraisal by the Ninth Circuit that considered the trial court’s UCL ruling worth reviewing. Judge Yvonne Gonzalez Rogers’ decision called Apple’s app distribution system a “black box,” and struck down the anti-steering provisions to enhance competition, transparency, and consumer choice and information while preserving Apple’s iOS ecosystem.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas